Business ❯ Pharmaceutical Industry

Drug Manufacturing

Pricing Strategies Quality Control Investment Market Competition Regulatory Compliance Investment Strategies Cost Management Novo Nordisk Supply Chain Management Export Regulations

Lilly Urges Recall After Finding New Impurity in Compounded Tirzepatide With B12

The warning focuses on mass-marketed 'personalized' versions sold outside FDA review.

Indian National Sentenced to 43 Months for Counterfeit Keytruda Scheme

TrumpRX.gov Launches With 40+ Lower-Priced Drugs as Companies Announce Cuts

GLP-1 Weight-Loss Push Intensifies as Novo Leads Ads and Wegovy Pill Drives Telehealth Uptake

Wegovy Pill Debuts to Strong U.S. Demand as Next‑Gen Obesity Drugs Near Decisions

Chicago Nurse Pleads Not Guilty to Federal Charges Over Counterfeit ‘Ozempic’ Injections

Delhi High Court Allows Zydus to Market Nivolumab Biosimilar on Public‑Interest Grounds

Argentina Names Luis Fontana to Lead ANMAT After Fentanyl Scandal

Trump Aide’s Son Criticized for Citing Brother’s Overdose to Defend U.S. Action on Venezuela

UK Sounds Alarm on Slimming Jabs After 60% Rise in Suspected Hospital Cases

Telangana Drug Regulator Logs 244 Seizures in 2025, First Arrests in Spurious-Drug Cases

Indian Immunologicals Challenges Australia’s Rabies Vaccine Alert as Reports Flag Communication Gaps

Anvisa Bans Sales and Advertising of Raia Drogasil’s Needs and Bwell Medicines

Investigation Finds Banned Insulin Still Dispensed in Peru Despite Recall Order

White House Adds 9 Pharma Deals, Extending Drug-Price Pacts to 14 Manufacturers

ED Secures Six-Day Custody After Arresting Punjab Businessman in Psychotropic Drug Laundering Case

FDA Fast-Tracks Augmentin XR in First Approval Under National Priority Voucher Pilot

Brazilian Police Target Alleged Illicit Tirzepatide Network Linked to Influencer Doctor

US FDA Clears Lupin’s Armlupeg, a Neulasta Biosimilar, for U.S. Use

India Moves to Ban High-Risk Solvents in Children’s Syrups, Shift Cough Syrups to Prescription-Only